These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34119037)

  • 1. COVID-19: Colorectal cancer endoscopic surveillance in IBD.
    Din S; Gaya DR; Arnott IDR
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):526-527. PubMed ID: 34119037
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of COVID-19 on the detection and management of colorectal cancer in England.
    Tiernan JP; Davies MM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):342. PubMed ID: 33857442
    [No Abstract]   [Full Text] [Related]  

  • 3. Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy. A retrospective co-operative IG-IBD study.
    Riegler G; Bossa F; Caserta L; Pera A; Tonelli F; Sturniolo GC; Oliva L; Contessini Avesani E; Poggioli G;
    Dig Liver Dis; 2003 Sep; 35(9):628-34. PubMed ID: 14563184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of COVID-19 on colorectal cancer care in England.
    Turnbull C
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):152-154. PubMed ID: 33453764
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.
    Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A
    BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the first peak of the COVID-19 pandemic on colorectal cancer services in England and Wales: A national survey, by Boyle et al.
    Burns E
    Colorectal Dis; 2021 Jul; 23(7):1612. PubMed ID: 34263522
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorectal cancer screening and the COVID-19 pandemic - Lessons learnt.
    Halloran SP
    Prev Med; 2021 Oct; 151():106539. PubMed ID: 34217407
    [No Abstract]   [Full Text] [Related]  

  • 8. Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions.
    Kopel J; Ristic B; Brower GL; Goyal H
    Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic surveillance of colorectal cancer in inflammatory bowel diseases: a review of the literature.
    Vitello A; Shahini E; Macaluso FS; Morreale GC; Sinagra E; Pallio S; Maida M
    Expert Rev Anticancer Ther; 2020 Oct; 20(10):851-863. PubMed ID: 32811225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 on colorectal cancer early diagnosis pathway: retrospective cohort study.
    Abdellatif M; Salama Y; Alhammali T; Eltweri AM
    Br J Surg; 2021 Apr; 108(4):e146-e147. PubMed ID: 33792641
    [No Abstract]   [Full Text] [Related]  

  • 11. Colorectal Cancer Screening: Where We Are and Moving Forward.
    Lightdale CJ
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):xiii-xiv. PubMed ID: 32439092
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds.
    Bezzio C; Manes G; Bini F; Pellegrini L; Saibeni S
    Gut; 2021 Mar; 70(3):623-624. PubMed ID: 32554621
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Barrett K; Habib Bedwani N; Arya S; Bhargava A
    Br J Surg; 2020 Oct; 107(11):e531-e532. PubMed ID: 32871025
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the COVID-19 pandemic on colorectal cancer care in France.
    Priou S; Lamé G; Chatellier G; Tournigand C; Kempf E
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):342-343. PubMed ID: 33857441
    [No Abstract]   [Full Text] [Related]  

  • 16. Impairment of colorectal cancer screening during the COVID-19 pandemic.
    Semenov S; Ismail MS; McNamara D
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):426. PubMed ID: 34015353
    [No Abstract]   [Full Text] [Related]  

  • 17. Impairment of colorectal cancer screening during the COVID-19 pandemic.
    Laghi L; Cameletti M; Ferrari C; Ricciardiello L
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):425-426. PubMed ID: 34015352
    [No Abstract]   [Full Text] [Related]  

  • 18. The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis.
    Aziz M; Fatima R; Haghbin H; Lee-Smith W; Nawras A
    Inflamm Bowel Dis; 2020 Sep; 26(10):e132-e133. PubMed ID: 32619003
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: "Colorectal screening: We have not caught up. A surge of colorectal cancer after the coronavirus disease 2019 (COVID-19) pandemic?".
    Mak VP; Le Marchand L
    Surgery; 2021 Jul; 170(1):348-349. PubMed ID: 33781585
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?
    Attauabi M; Seidelin J; Burisch J;
    Gut; 2021 Oct; 70(10):2020-2022. PubMed ID: 33658323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.